Insulin Degludec
Brand name: Tresiba Flextouch U-100
Rank #33 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$567.8M
Total Cost
597,178
Total Claims
$567.8M
Total Cost
20,772
Prescribers
$951
Cost per Claim
84,301
Beneficiaries
1,129,297
30-Day Fills
$27K
Avg Cost/Provider
29
Avg Claims/Provider
Share of Medicare Part D Spending
0.21%
of total Medicare Part D spending
$567.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $567.8M total
🔎 Data Overview
Ranked #33 out of 500 drugs tracked by total cost. Insulin Degludec represents a significant portion of Medicare drug spending.
Average cost of $6,736 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Insulin Degludec
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jaweed Akhter | Endocrinology | Beaumont, TX | 760 | $1.2M |
| 2 | Charla Yassine | Certified Clinical Nurse Specialist | Wichita, KS | 491 | $793K |
| 3 | K. Thampy | Endocrinology | Saint Louis, MO | 702 | $761K |
| 4 | Kelsey Barr | Endocrinology | Pollocksville, NC | 458 | $638K |
| 5 | Wendy Sanders | Nurse Practitioner | Cedar Rapids, IA | 459 | $632K |
| 6 | Susan Murry | Nurse Practitioner | Bryan, OH | 286 | $590K |
| 7 | K. Thampy | Endocrinology | Saint Louis, MO | 288 | $583K |
| 8 | Ralph Teague | Endocrinology | Birmingham, AL | 326 | $537K |
| 9 | Ernest Asamoah | Endocrinology | Indianapolis, IN | 272 | $488K |
| 10 | Patrick Richards | Endocrinology | Sacramento, CA | 348 | $482K |
| 11 | Rae Jessee | Nurse Practitioner | Maysville, KY | 270 | $475K |
| 12 | Sonia Eapen | Endocrinology | Pearland, TX | 309 | $462K |
| 13 | Hanna Henderson | Nurse Practitioner | Knoxville, TN | 194 | $461K |
| 14 | Nitika Malhotra | Endocrinology | Jacksonville, FL | 381 | $452K |
| 15 | David Domenichini | Endocrinology | Bloomfield, CT | 231 | $448K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 30 | Rsvpref3 Antigen/As01e/Pf (Arexvy) | $608.6M | 1,935,431 |
| 31 | Pomalidomide (Pomalyst) | $589.0M | 27,253 |
| 32 | Lipase/Protease/Amylase (Zenpep) | $577.7M | 321,809 |
| 33 | Insulin Degludec (Tresiba Flextouch U-100) | $567.8M | 597,178 |
| 34 | Valbenazine Tosylate (Ingrezza) | $553.8M | 73,914 |
| 35 | Fluticasone Propion/Salmeterol (Advair Diskus) | $523.2M | 1,289,942 |
| 36 | Varicella-Zoster Ge/As01b/Pf (Shingrix) | $514.4M | 2,419,884 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology